DA32 LIFE SCIENCE TECH ACQUISITION CORP.

(DALS)
Delayed Nasdaq  -  05/26 02:00:56 pm EDT
9.650 USD    0.00%
05/13DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/13DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/31DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.

01/23/2022 EDT

Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022. These Class B Common Stock will be under lockup for 180 days starting from 27-JUL-2021 to 23-JAN-2022. Details: The directors and executive officers and holders of substantially all of its stockholders have agreed they will not, subject to certain exceptions offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any shares of capital stock or any securities convertible into, or exercisable or exchangeable for such capital stock, or publicly announce an intention to effect any such transaction, whether any transaction is to be settled by delivery of common stock or such other securities, in cash or otherwise during the period ending 180 days from the date of this prospectus, without the prior written consent of J.P. Morgan Securities LLC and Cowen and Company, LLC.


© S&P Capital IQ 2022
All news about DA32 LIFE SCIENCE TECH ACQUISITION CORP.
05/13DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Finan..
AQ
05/13DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter..
CI
03/31DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINAN..
AQ
03/31DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months ..
CI
01/23Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to..
CI
2021DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Finan..
AQ
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Other Events (form 8-K)
AQ
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Sponsored by Deerfield, ARCH Venture Partners and S..
BU
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Entry into a Material Definitive Agreement, Unregis..
AQ
2021DA32 Life Science Tech Acquisition Corp. Announces Executive Changes
CI
More news
Financials (USD)
Sales
Net income
Net Debt
P/E ratio
Yield
Capitalization 248 M 248 M -
EV / Sales -1
EV / Sales 0
Nbr of Employees -
Free-Float 74,9%
Chart DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Duration : Period :
DA32 Life Science Tech Acquisition Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Steven J. Kafka Chief Executive Officer & Director
Christopher E. Wolfe Chief Financial Officer & Secretary
Mara G. Aspinall Independent Director
E. Kevin Hrusovsky Independent Director
Nicolas Henry Roelofs Independent Director
Sector and Competitors